Iclusig and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Iclusig (ponatinib hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Sprycel, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Joint pain when taking Iclusig. It is created by eHealthMe based on reports of 6,108 people who have side effects when taking Iclusig from the FDA, and is updated regularly.

What is Iclusig?

Iclusig has active ingredients of ponatinib hydrochloride. eHealthMe is studying from 6,109 Iclusig users. Check the latest studies of Iclusig.

What is Joint pain?

Joint pain is found to be associated with 3,332 drugs and 5,203 conditions by eHealthMe. Check the latest studies of Joint pain.

On Jul, 08, 2026

6,108 people reported to have side effects when taking Iclusig.
Among them, 248 people (4.06%) have Joint pain.

Among these 248 people:

* Approximation only. Some reports may have incomplete information.

Do you take Iclusig and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Iclusig:

Iclusig (6,109 reports)

Joint pain treatments and more:

Joint pain (542,934 reports)

How severe was Joint pain and when was it recovered:

Joint pain in Iclusig

Expand to all the drugs that have ingredients of ponatinib hydrochloride:

Joint pain and drugs with ingredients of ponatinib hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Iclusig:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,332 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,203 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ponatinib hydrochloride (the active ingredients of Iclusig) and Iclusig (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.